Cognition, reserve, and amyloid deposition in normal aging - PubMed (original) (raw)
Cognition, reserve, and amyloid deposition in normal aging
Dorene M Rentz et al. Ann Neurol. 2010 Mar.
Free PMC article
Abstract
Objective: To determine whether amyloid deposition is associated with impaired neuropsychological (NP) performance and whether cognitive reserve (CR) modifies this association.
Methods: In 66 normal elderly controls and 17 patients with Alzheimer disease (AD), we related brain retention of Pittsburgh Compound B (PiB) to NP performance and evaluated the impact of CR using education and American National Adult Reading Test intelligence quotient as proposed proxies.
Results: We found in the combined sample of subjects that PiB retention in the precuneus was inversely related to NP performance, especially in tests of memory function, but also in tests of working memory, semantic processing, language, and visuospatial perception. CR significantly modified the relationship, such that at progressively higher levels of CR, increased amyloid deposition was less or not at all associated with poorer neuropsychological performance. In a subsample of normal controls, both the main effect of amyloid deposition of worse memory performance and the interaction with CR were replicated using a particularly challenging memory test.
Interpretation: Amyloid deposition is associated with lower cognitive performance both in AD patients and in the normal elderly, but the association is modified by CR, suggesting that CR may be protective against amyloid-related cognitive impairment.
Figures
FIGURE 1
Neuropsychological performance versus precuneus Pittsburgh Compound B (PiB) retention. In each panel, subjects are color-coded by tertile strata of increasing cognitive reserve (CR), expressed as residual American National Adult Reading Test (AMNART) intelligence quotient (IQ): low, medium, and high. Solid lines represent the ordinary least squares regression lines for each stratum. Note that data points shown are not adjusted for age or education, as in the regression analyses (see Table 2). (A) In the full sample of subjects (N = 83), neuropsychological (NP) performance represented by the canonical variate was inversely related to PiB retention, but the effect was attenuated at higher levels of IQ. (B) In the subset of PiB-positive subjects (defined as global mean cortical PiB distribution volume ratio [DVR] ≥ 1.15; n = 55), canonical variate NP performance was inversely related to PiB retention, but no interaction with CR was observed, that is, regression lines are nearly parallel. (C) In the subset of NC subjects (n = 66), the relation of canonical variate NP performance to PiB retention did not reach significance; instead, the significant interaction effect with CR resulted in a systematic splaying of the data according to CR, identified as strata of AMNART IQ. (D) In the further subset of NC subjects with data from the more challenging MCT (n = 34), both a significant main effect of PiB on NP performance and a significant interaction with CR were observed. NC-MCT = normal control Memory Capacity Test.
Similar articles
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.
Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, Masters CL, Rowe CC. Villemagne VL, et al. Ann Neurol. 2011 Jan;69(1):181-92. doi: 10.1002/ana.22248. Ann Neurol. 2011. PMID: 21280088 Free PMC article. - Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.
Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ. Perrotin A, et al. Arch Neurol. 2012 Feb;69(2):223-9. doi: 10.1001/archneurol.2011.666. Arch Neurol. 2012. PMID: 22332189 Free PMC article. - PET imaging of amyloid deposition in patients with mild cognitive impairment.
Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, Långström B, Nordberg A. Forsberg A, et al. Neurobiol Aging. 2008 Oct;29(10):1456-65. doi: 10.1016/j.neurobiolaging.2007.03.029. Epub 2007 May 11. Neurobiol Aging. 2008. PMID: 17499392 - Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.
Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Research Group. Chételat G, et al. Ann Neurol. 2010 Mar;67(3):317-24. doi: 10.1002/ana.21955. Ann Neurol. 2010. PMID: 20373343 - Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC. Doré V, et al. JAMA Neurol. 2013 Jul;70(7):903-11. doi: 10.1001/jamaneurol.2013.1062. JAMA Neurol. 2013. PMID: 23712469
Cited by
- The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, DeCarli C, Weiner MW, Mungas DM, Chui HC, Jagust WJ. Marchant NL, et al. JAMA Neurol. 2013 Apr;70(4):488-95. doi: 10.1001/2013.jamaneurol.405. JAMA Neurol. 2013. PMID: 23400560 Free PMC article. - The memory binding test can anticipate Alzheimer's disease diagnosis at an early preclinical stage: a longitudinal study in the INSIGHTpreAD cohort.
Raposo Pereira F, George N, Dalla Barba G, Dubois B, La Corte V. Raposo Pereira F, et al. Front Aging Neurosci. 2024 Aug 8;16:1414419. doi: 10.3389/fnagi.2024.1414419. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39175810 Free PMC article. - Predicting positron emission tomography brain amyloid positivity using interpretable machine learning models with wearable sensor data and lifestyle factors.
Kimura N, Aota T, Aso Y, Yabuuchi K, Sasaki K, Masuda T, Eguchi A, Maeda Y, Aoshima K, Matsubara E. Kimura N, et al. Alzheimers Res Ther. 2023 Dec 12;15(1):212. doi: 10.1186/s13195-023-01363-x. Alzheimers Res Ther. 2023. PMID: 38087316 Free PMC article. - Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play.
Jack CR Jr. Jack CR Jr. Radiology. 2012 May;263(2):344-61. doi: 10.1148/radiol.12110433. Radiology. 2012. PMID: 22517954 Free PMC article. Review. - Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers.
Gidicsin CM, Maye JE, Locascio JJ, Pepin LC, Philiossaint M, Becker JA, Younger AP, Dekhtyar M, Schultz AP, Amariglio RE, Marshall GA, Rentz DM, Hedden T, Sperling RA, Johnson KA. Gidicsin CM, et al. Neurology. 2015 Jul 7;85(1):48-55. doi: 10.1212/WNL.0000000000001704. Epub 2015 Jun 10. Neurology. 2015. PMID: 26062627 Free PMC article.
References
- Arriagada PV, Growdon JH, Hedley-White ET, et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992;42:631–639. - PubMed
- Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 1992;42:1681–1688. - PubMed
- Duyckaerts C, Colle MA, Dessi F, et al. Progression of Alzheimer histopathological changes. Acta Neurol Belg. 1998;98:180–185. - PubMed
- Giannakopoulos P, Herrmann FR, Bussiere T, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology. 2003;60:1495–1500. - PubMed
- Ingelsson M, Fukumoto H, Newell KL, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology. 2004;62:925–931. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AG00513421/AG/NIA NIH HHS/United States
- R01 AG034556-02/AG/NIA NIH HHS/United States
- R01 AG027435/AG/NIA NIH HHS/United States
- AG021910/AG/NIA NIH HHS/United States
- R01 AG034556-03/AG/NIA NIH HHS/United States
- R01 AG021910-05/AG/NIA NIH HHS/United States
- R01 AG034556/AG/NIA NIH HHS/United States
- AG027435-S1/AG/NIA NIH HHS/United States
- R01 AG027435-05/AG/NIA NIH HHS/United States
- R01 AG034556-01/AG/NIA NIH HHS/United States
- R01 AG021910/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous